Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.

AIDS patient care and STDs - 1 Feb 2020

Meybeck Agnès, Alidjinou Enagnon Kazali, Huleux Thomas, Boucher Anne, Tetart Macha, Choisy Philippe, Bocket Laurence, Ajana Faiza, Robineau Olivier

Abstract excerpt

Issues have been raised concerning clinical relevance of HIV-1 proviral DNA genotypic resistance test (DNA GRT). To assess impact of DNA GRT on choice of antiretroviral therapy (ART) and subsequent virological outcome, we retrospectively reviewed decision-making and viral load (VL) evolution following DNA GRT performed in our center between January 2012 and December 2017, except those prescribed within the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Anti-Retroviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiretroviral Therapy, Highly Active

Share to CD4 Lymphocyte Count

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Viral Load

Share to Viremia

Source

Identifiers

PMID: 32049556
DOI: 10.1089/apc.2019.0198

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.PMID 32049556Read ↗

Clinical Outcomes Following the Use of Archived Proviral HIV-1 DNA Genotype to Guide Antiretroviral Therapy AdjustmentSemantic proximity Read ↗

Archived HIV-1 Drug Resistance Mutations: Role of Proviral HIV-1 DNA Genotype for the Management of Virological Responder People Living with HIV.Semantic proximity Read ↗

The use of human immunodeficiency virus resistance tests in clinical practice.Semantic proximity Read ↗

Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear CellsSemantic proximity Read ↗

Reliability and Clinical Relevance of the HIV-1 Drug Resistance Test in Patients With Low Viremia LevelsSemantic proximity Read ↗

Using HIV resistance tests in clinical practice.Semantic proximity Read ↗

Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA.Semantic proximity Read ↗

Optimizing Antiretroviral Therapy in Heavily ART-Experienced Patients with Multi-Class Resistant HIV-1 Using Proviral DNA Genotypic Resistance Testing.Semantic proximity Read ↗

Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirineSemantic proximity Read ↗

Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.Semantic proximity Read ↗

Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals.Semantic proximity Read ↗

Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.